APA (7th ed.) Citation

Liu, X., Moamer, A., Silva, R. G. d., Shoham-Amizlev, A., Hamam, D., Shams, A., . . . Ali, S. A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Liu, Xueqing, Alaa Moamer, Roger Gomes da Silva, Aidan Shoham-Amizlev, Dana Hamam, Anwar Shams, Jean-Jacques Lebrun, and Suhad Ali. A Novel Clinically Relevant Antagonistic Interplay Between Prolactin and Oncogenic YAP-CCN2 Pathways as a Differentiation Therapeutic Target in Breast Cancer. Nature Publishing Group.

MLA (9th ed.) Citation

Liu, Xueqing, et al. A Novel Clinically Relevant Antagonistic Interplay Between Prolactin and Oncogenic YAP-CCN2 Pathways as a Differentiation Therapeutic Target in Breast Cancer. Nature Publishing Group.